Wendy M. Ma

Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries

K. Fagerström, C. Russ, Hong-Jun Cho, 2010, Current medical research and opinion.

A Randomized Trial Of Varenicline For Smoking Cessation In Patients With Mild To Moderate Chronic Obstructive Pulmonary Disease (COPD): Analysis Of Efficacy By Baseline Characteristics

S. Rennard, D. Tashkin, Theodore C. Lee, 2010, ATS 2010.

EFFICACY AND SAFETY OF VARENICLINE FOR SMOKING CESSATION IN PATIENTS WITH MILD TO MODERATE COPD

S. Rennard, D. Tashkin, T. Lee, 2009 .

Low-dose cytarabine with or without glasdegib in newly diagnosed patients with acute myeloid leukemia: Long-term analysis of a phase 2 randomized trial.

M. Heuser, J. Cortes, B. Smith, 2019, Journal of Clinical Oncology.

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.

S. Rennard, D. Lawrence, D. Tashkin, 2011, Chest.

Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease

Qinying Zhao, M. Bednar, A. Burstein, 2010, Alzheimer's & Dementia.

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.

S. Rennard, D. Lawrence, D. Tashkin, 2011, Chest.

What Justifies a Placebo-Controlled Trial of Varenicline for Smoking Cessation in Patients With COPD?: Response

S. Rennard, D. Lawrence, D. Tashkin, 2011 .